The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
2022 · Blood · 1,387 citations
https://doi.org/10.1182/blood.2022015851
P
Paolo Ghia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.1K
Papers
37.0K
Citations
93
h-index
384
i10-index
Paolo Ghia is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 93, co-authored 913 publications.
ORCID: 0000-0003-3750-7342Papers by this author
worksLong-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
2015 · Blood · 692 citations
https://doi.org/10.1182/blood-2015-06-651125
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2020 · Annals of Oncology · 553 citations
https://doi.org/10.1016/j.annonc.2020.09.019
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
2019 · Leukemia · 447 citations
https://doi.org/10.1038/s41375-019-0602-x
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
2017 · The Lancet Oncology · 247 citations
https://doi.org/10.1016/s1470-2045(16)30671-4
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
2022 · Leukemia · 194 citations
https://doi.org/10.1038/s41375-021-01485-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat